Capping drug prices will not merely lower profits while preserving innovation; firms will abandon exotic diseases and unpromising paths, so the surviving projects earn higher returns and political pressure then restarts the cycle.

forecastpending

Speaker

Richard Epstein

Evidence Quote

“they will stop going after exotic diseases, they will stop going into new paths, and they will essentially kill all those projects that don't have a higher rate of return”

Source

Richard Epstein on Property Rights and Drug Patents 2/19/2007— EconTalk
Created: 10/30/2026, 3:22:16 PM

Your notes

Loading notes...